Loading...
Antiepileptic drugs (AEDs) are used frequently in patients with HIV infection to treat epilepsy, reactive seizures symptomatic of opportunistic infections, and, increasingly, symptomatic peripheral neuropathy. Enzyme-inducing AEDs (EI AEDs) are of particular concern because of the high likelihood of significant interactions with antiretroviral (ARV) medications and more-frequent use in low- to middle-income countries.
Now, the first evidence-based guidelines on AED use in patients with HIV infection have been created by a joint panel of the American Academy of Neurology, the International League Against Epilepsy, and the WHO. The panel conducted a systematic review of evidence from 1950 through 2010 to estimate the prevalence of AED-ARV coad…